E-Rare associates with Blackswan Foundation to co-organize 4th International Congress on Reaserch of Rare and Orphan Diseases - RE(ACT) 2018.

The congress will take place from 7-10 of March 2018 in Bologna, Italy.

 

We invite you to join us at the 3rd conference of the International Rare Diseases Research Consortium (IRDiRC), which will take place February 8-9, 2017 in Paris, France at the conference center of Université Pierre et Marie Curie (UPMC) Jussieu.

For more information and registration

 The E-Rare 9th call for projects opened on the 5th of December 2017. The 1st stage of application in now closed.

The aim of the call is the development of novel therapeutic approaches for rare diseases. 17 countries participate in the call.

 

For more information

 

European Medicines Agency has published the final guidance document for applicants to Horizon 2020 topic “New therapies for rare diseases” on the EMA website. Find more information HERE

EMA publishes guidelines for applicants to H2020 rare diseases calls

EMA publishes guidelines for applicants to H2020 rare diseases calls

European Medicines Agency has published the final guidance document for applicants to Horizon 2020 topic “New therapies for rare diseases” on the EMA website.

This document is specifically targeted to academic applicants to Horizon 2020 with the aim to outline some regulatory concepts and the time-frame of orphan designation and protocol assistance procedure.

You will find more information on: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/gen...

The link to download the PDF version of guidelines click HERE

E-Rare 2012 - Created by Toussaint Biger